PRQR stock - ProQR Therapeutics N.V.

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

Fri 16'th Nov 2018

PERIOD 2018-08-17 - 2018-11-16
CHANGE 4.83%
PRICE $20.42
VOLUME
Sell
TREND
Buy

MV LONG
Buy

MV SHORT
Buy

PIVOT
Buy

MACD
Buy
Request Prediction
0.00%
Predict

ProQR Therapeutics N.V. Stock Analysis

Technical stock analysis for Fri 16'th Nov 2018

Buy candidate since 2018-11-15 Gain 4.83%
Shorts n/a
Cash n/a
Loans n/a
Beta 0.54
ROA -42.72

ProQR Therapeutics N.V. gained 4.83% in the last trading day, rising from $19.48 to $20.42 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has fallen in 6 of the last 10 days and is down by -8.84% for this period. Volume fell in the last day by -338 733 shares, and in total, 536 568 shares bought and sold for approximately $10.96 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Trend

ProQR Therapeutics N.V. lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 55.8% during the next 3 months and, with 90% probability hold a price between $27.16 and $46.01 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

Only positive signals in the chart today. ProQR Therapeutics N.V. holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $19.20 and $18.90. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday November 14, 2018, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 62 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

On the downside, the stock finds support just below today's level from accumulated volume at $18.65 and $17.55.

There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, ProQR Therapeutics N.V. finds support just below today's level at $18.65. If this is broken, then the next support from accumulated volume will be at $17.55 and $15.80.

Support: $18.65 Price: $20.42 Resistance: $20.80

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.59 between high and low, or 8.23%. For the last week, the stock has had a daily average volatility of 8.27%.

Our recommended stoploss: $19.55 (-4.28%) (This stock has high daily movements and this gives high risk. There is a buy signal from pivot bottom found 2 days ago.)

Overall risk:

Very Low Low Medium High Very High

Evaluation

ProQR Therapeutics N.V. holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.

PRQR $20.42 $0.94(4.83%)
PRQR is up $0.94 today, but where's it headed in 2019?
Zacks Investment Research is releasing its prediction for PRQR based on the 1-3 month system that more than doubles the S&P 500.

Click here – the PRQR analysis is free »

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Proudly made at


in partnership with